A major goal of the DF/HCC GI SPORE is to identify and fund projects that will lead to clinically testable hypotheses aimed at reducing the incidence and mortality rate of GI cancers or improving the quality of life of patients with GI cancers. The Developmental Research Program (DRP) supports short-range studies to establish the results needed to facilitate well-validated, hypothesis-driven translational projects. Although the DRP funds established investigators, an important goal is to identify and stimulate interest in GI cancer research among groups whose current focus may be different but sufficiently related. The Developmental Projects Program is led a highly qualified committee of DF/HCC researchers who participate actively in the selection and ongoing review of pilot projects and who represent laboratory, population and clinical science across the Harvard institutions. The DRP provides the depth and flexibility required to maintain innovation in GI SPORE activities. During the prior funding cycle, the DF/HCC SPORE supported 18 highly innovative and productive developmental projects that have enabled novel discoveries and 29 successful grant applications to further their ongoing research. The DRP will continue to support novel research in GI cancer and has the following specific aims: 1. Solicit pilot projects in GI cancer translational research that have significant potential for reducing the incidence and mortality rate of GI cancer and/or improving the quality of life of patients with GI cancers. 2. Foster collaborative efforts among SPORE investigators and with other investigators to encourage the development of new and innovative ideas and approaches. 3. Monitor the progress of the projects and provide critical feedback. 4. Encourage and assist investigators with promising preliminary data developed with support of this Program to apply for extramural peer-reviewed funding. 5. When necessary or possible, promote the most promising projects in the Developmental Research Program to full SPORE research projects.

Public Health Relevance

The DF/HCC GI SPORE Developmental Research Program seeks to support and nurture new innovative research efforts aimed at reducing the incidence and mortality rate of GI cancers or improving the quality of life of patients with GI cancers. To date, the Program has supported 18 novel and productive projects that are making meaningful discoveries in our understanding of GI cancer biology, prevention, and therapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA127003-06A1
Application #
8485730
Study Section
Special Emphasis Panel (ZCA1-RPRB-M (J1))
Project Start
2007-04-01
Project End
2018-06-30
Budget Start
2013-09-23
Budget End
2014-06-30
Support Year
6
Fiscal Year
2013
Total Cost
$184,669
Indirect Cost
$79,650
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Schaefer, Inga-Marie; Wang, Yuexiang; Liang, Cher-Wei et al. (2017) MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation. Nat Commun 8:14674
Larimer, Benjamin M; Wehrenberg-Klee, Eric; Dubois, Frank et al. (2017) Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response. Cancer Res 77:2318-2327
Yang, Wanshui; Liu, Li; Masugi, Yohei et al. (2017) Calcium intake and risk of colorectal cancer according to expression status of calcium-sensing receptor (CASR). Gut :
Shi, Yan; Qian, Zhi Rong; Zhang, Sui et al. (2017) Cell Cycle Protein Expression in Neuroendocrine Tumors: Association of CDK4/CDK6, CCND1, and Phosphorylated Retinoblastoma Protein With Proliferative Index. Pancreas 46:1347-1353
Lopes-Ramos, Camila M; Paulson, Joseph N; Chen, Cho-Yi et al. (2017) Regulatory network changes between cell lines and their tissues of origin. BMC Genomics 18:723
Lindström, Sara; Finucane, Hilary; Bulik-Sullivan, Brendan et al. (2017) Quantifying the Genetic Correlation between Multiple Cancer Types. Cancer Epidemiol Biomarkers Prev 26:1427-1435
Keum, NaNa; Yuan, Chen; Nishihara, Reiko et al. (2017) Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers. Int J Cancer 140:2648-2656
Boland, C Richard; Yurgelun, Matthew B (2017) Historical Perspective on Familial Gastric Cancer. Cell Mol Gastroenterol Hepatol 3:192-200
Paulson, Joseph N; Chen, Cho-Yi; Lopes-Ramos, Camila M et al. (2017) Tissue-aware RNA-Seq processing and normalization for heterogeneous and sparse data. BMC Bioinformatics 18:437
Wei, Esther K; Colditz, Graham A; Giovannucci, Edward L et al. (2017) A Comprehensive Model of Colorectal Cancer by Risk Factor Status and Subsite Using Data From the Nurses' Health Study. Am J Epidemiol 185:224-237

Showing the most recent 10 out of 543 publications